Carcinoma of the Lung

  • M. K. Wood
  • S. G. Spiro


Lung cancer is the commonest cause of fatal malignancy worldwide, with over 900 000 deaths per year (1). The incidence is increasing in developing countries, where the rate was once relatively low. In eastern Asia and China, where the control of tobacco advertising and general public awareness is minimal, the mortality rates are higher than the world average. In developed countries the incidence among women has been rising steadily, matching the increased smoking habits of women since the 1950s (2,3). Smoking causes 85–90% of all lung cancers and it is only in countries with high profile anti-smoking lobbies where the incidence is decreasing. In America there has been a fall in the number of smokers, with a subsequent fall in the incidence of lung cancer in men every year for the last 5 years. The incidence among women, however, only began to plateau in the mid 1990s, which is a 10 year lag behind lung cancer rates in men and reflects smoking habits among American women (4).


Lung Cancer Main Bronchus Bronchogenic Carcinoma Allergic Bronchopulmonary Aspergillosis Sputum Cytology 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Pisani P, Parkin DM, Bray F, et al. (1999) Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83:18–29.PubMedCrossRefGoogle Scholar
  2. 2.
    Hill C (1998) Trends in tobacco smoking and consequences on health in France. Prev Med 27:514–519.PubMedCrossRefGoogle Scholar
  3. 3.
    Devesa SS, Grauman DJ, Blot WJ, et al. (1999) Cancer surveillance series: Changing geographic patterns of lung cancer mortality in the United States, 1950 through 1994. J Natl Cancer Inst 91:1040–1050.PubMedCrossRefGoogle Scholar
  4. 4.
    Garfinkel L, Mushinski M (1999) U.S. cancer incidence, mortality and survival: 1973-1996. Stat Bull Metrop Insur Co 80:23–32.PubMedGoogle Scholar
  5. 5.
    Arai T, Kuroishi T, Saito Y, et al. (1994) tumor doubling time and prognosis in lung cancer patients: Evaluation from chest films and clinical follow-up study. Japanese Lung Cancer Screening Research Group. Jpn J Clin Oncol 24:199–204.Google Scholar
  6. 6.
    Theros EG (1977) Caldwell Lecture: Varying manifestations of peripheral pulmonary neoplasms: A radiologie-pathologie correlative study. AJR 128:893–914.PubMedGoogle Scholar
  7. 7.
    Strauss MJ (1974) The growth characteristics of lung cancer and its application to treatment design. Semin Oncol 1:167–174.Google Scholar
  8. 8.
    Garland LH (1966) The rate of growth and natural duration of primary bronchial cancer. Am J Radiol 96:604–611.Google Scholar
  9. 9.
    Strauss GM, Dominioni L (1999) Lung cancer screening and the surgical oncologist: the controversy. Surg Oncol Clin North Am 8:372–387.Google Scholar
  10. 10.
    Henschke CI, McCauley DI, Yankelevitz DF, et al. (1999) Early Lung Cancer Action Project: Overall design and findings from baseline screening. Lancet 354:99–105.PubMedCrossRefGoogle Scholar
  11. 11.
    Patel AM, Davila DG, Peters SG (1993) Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc 68:278–287.PubMedGoogle Scholar
  12. 12.
    Schiller JH, Jones JC (1993) Paraneoplastic syndromes associated with lung cancer. Curr Opin Oncol 5:335–342.PubMedCrossRefGoogle Scholar
  13. 13.
    Kern WH (1988)The diagnostic accuracy of sputum and urine cytology. Acta Cytol 32:651–654.PubMedGoogle Scholar
  14. 14.
    MacDouggall B, Weinerman B (1992) The value of sputum cytology. J Gen Intern Med 7:11–13.CrossRefGoogle Scholar
  15. 15.
    Sing A, Freudenberg N, Kortsik C, et al. (1997) Comparison of sensitivity of sputum and brush cytology in the diagnosis of lung carcinomas. Acta Cytol 41:399–408.PubMedCrossRefGoogle Scholar
  16. 16.
    Khajotia RR, Mohn A, Pokieser L, et al. (1991) Induced sputum and cytological diagnosis of lung cancer. Lancet 338:976–977.PubMedCrossRefGoogle Scholar
  17. 17.
    Larscheid RC, Thorpe PE, Scott WJ (1998) Percutaneous transthoracic needle aspiration biopsy: A comprehensive review of its current role in the diagnosis and treatment of lung tumors. Chest 114:704–709.PubMedCrossRefGoogle Scholar
  18. 18.
    Odell M J, Reid KR (1999) Does percutaneous fine-needle aspiration biopsy aid in the diagnosis and surgical management of lung masses? Can J Surg 42:297–301.PubMedGoogle Scholar
  19. 19.
    Sheth S, Hamper UM, Stanley DB, et al. (1999) US guidance for thoracic biopsy: A valuable alternative to CT. Radiology 210:721–726.PubMedGoogle Scholar
  20. 20.
    Ghaye B, Dondelinger RF, Dewe W (1999) Percutaneous CT-guided lung biopsy: Sequential versus spiral scanning. A randomized prospective study. Eur Radiol 9:1317–1320.PubMedCrossRefGoogle Scholar
  21. 21.
    Cox JE, Chiles C, McManus CM, et al. (1999) Transthoracic needle aspiration biopsy: variables that affect risk of pneumothorax. Radiology 212:165–168.PubMedGoogle Scholar
  22. 22.
    Wyser C, Stulz P, Soler M, et al (1999) Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med 159:1450–1456.PubMedGoogle Scholar
  23. 23.
    Batra P, Brown K Steckel RJ, et al. (1988) MR imaging of the thorax: A comparison of axial, coronal and saggital imaging planes. J Comput Assist Tomogr 12:75–78.PubMedCrossRefGoogle Scholar
  24. 24.
    Webb WR, Jensen BG, Gamsu G, et al. (1985) Sagittal MR imaging of the chest: Normal and abnormal. J Comput Assist Tomogr 9:471–479.PubMedCrossRefGoogle Scholar
  25. 25.
    Webb WR, Gatsonis C, Zerhouni E A, et al. (1991) CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the radiologic diagnostic oncology group. Radiology 178: 705–713.PubMedGoogle Scholar
  26. 26.
    Glazer GM, Gross BH, Aisen AM, et al. (1985) Imaging of the pulmonary hilum: A prospective comparative study in patients with lung cancer. Am J Radiol 145:245–248.Google Scholar
  27. 27.
    O’Connell RS, McLoud TC, Wilkin EW (1983) Superior sulcus tumor: Radiographic diagnosis and work up. Am J Radiol 140:25–30.Google Scholar
  28. 28.
    Castagno AA, Shuman WP (1987) MR imaging in clinically suspected brachial plexus tumor. Am J Radiol 149:1219–1222.Google Scholar
  29. 29.
    Salvatierra A, Baamonde C, Llamas JM, et al. (1990) Extrathoracic staging of bronchogenic carcinoma. Chest 97:1052–1058.PubMedCrossRefGoogle Scholar
  30. 30.
    Heelan RT, Demas BE, Caravelli J, et al. (1989) Superior sulcus tumors. CT MR Imaging Radiol 170:637–641.Google Scholar
  31. 31.
    Bittner RC, Felix R (1998) Magnetic resonance (MR) imaging of the chest: State-of-the-art. Eur Respir J 11:1392–1404.PubMedCrossRefGoogle Scholar
  32. 32.
    Sarinas PS, Chitkara RK, Buadu EO, et al. (1999) Usefulness of positron emission tomography imaging in the management of lung cancer. Curr Opin Pulm Med 5:201–207.PubMedCrossRefGoogle Scholar
  33. 33.
    Gdeedo A, Van Schil P, Corthouts B, et al. (1997) Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging. Eur Respir J 10:1547–1551.PubMedCrossRefGoogle Scholar
  34. 34.
    Mountain CF (1997) Revision in the International System for Staging Lung Cancer. Chest 111:1710–1717.PubMedCrossRefGoogle Scholar
  35. 35.
    Saunders M, Dische S, Barrett A, et al. on behalf of the CHART steering committee (1997) Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non small cell lung cancer: A randomised multicentre trial. Lancet 350:161–165.PubMedCrossRefGoogle Scholar
  36. 36.
    PORT Meta-analysis Trialists Group (1998) Postoperative radiotherapy on non-small cell lung cancer: Systematic review and metaanalysis of individual patient data from nine randomised controlled trials. Lancet 352:257–263.CrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2001

Authors and Affiliations

  • M. K. Wood
  • S. G. Spiro

There are no affiliations available

Personalised recommendations